Dow to Make Nine Technical Presentations and Exhibit at the AAPS Annual Meeting 2012 in Chicago USA
Midland, MI — October 11, 2012 -- Visit Dow (NYSE:DOW) at the AAPS Annual Meeting (American Association of Pharmaceutical Scientists), from October 14th to 18th, at the McCormick Center in Chicago, IL - booth 1824 - to learn more about how Dow is collaborating with formulators, pharmaceutical companies, distributors and industry experts to help develop the next generation of ingredients and solutions to make the world just a little healthier.
Increasingly, Dow people are earning a reputation as “go-to” solutions providers in the healthcare and medical markets. This is a direct result of Dow’s ability to work with those at all parts of the value chain, and deliver active ingredients, excipients, reagents and much more, consistently and reliably – and in a cost-effective manner – anywhere in the world.
Dow will share technical expertise at nine poster sessions during the show, covering insights in active ingredients, drug formulation and delivery, and Quality by Design in action. These include:
Monday, October 15th:
- Effect of Active Pharmaceutical Ingredients and Plasticizers on the Cloud Point of Hypromellose Formulations (Poster M1171)
- Understanding Polymer and Solution Attributes Necessary to Achieve Optimal Nasal Deposition (Poster; M1133)
- Rheological Properties of Hypromellose Solutions in the Presence of Salts (Poster M1185)
Tuesday, October 16th:
- Influence of Substrate Hydrophobicity on the Wettability of Very Low Viscosity Hypromellose Solutions for Tablet Coating Applications (Poster T2167)
- Improvements in Oxidative Stability of Polyethylene Oxide and the Impact in Oral Solid Dosage Forms ((Poster T2116)
- Effect of Plasticizer on the Properties of Hypromellose Film of Substitution Type 2910 (Poster T2194)
- Barrier and Disintegration Properties of Hot Melt Extruded Films (Poster T2155)
Wednesday, October 17th:
- Aspects of Foamed Binder Addition for Foam Granulation in a Twin Screw Extruder (Poster W4146)
- Impact of Substitution Level on Spray Dried Dispersions of Hypromellose Acetate Succinate – a Quality by Design Approach (Poster W5154)
Scientists, drug formulators, pharmaceutical companies and others who visit Dow’s booth at AAPS will learn more about the company’s extensive capabilities in helping to create and refine Active Pharmaceutical Ingredients (APIs), and its well-known expertise in ingredients for drug formulation and delivery.
Specific solutions and offerings to be highlighted include:
- CARBOWAX™ SENTRY™ high-purity polyethylene glycols which can be used as APIs or excipients, designed to meet compliance requirements of the pharmaceutical industry;
- VenPure™ Sodium Borohydride and Trimethyl Borate products designed to offer best-in-class efficiency for API synthesis;
- METHOCEL™ Premium VLV, our innovative very low viscosity tablet coating solution designed to optimize tablet manufacturing costs;
- Solubility enhancing solutions uniquely tailored to meet the solubilization performance requirements of each API;
- Quality by Design (QbD), how we can assist in developing clinically advantaged and robust formulations;
- Ion Exchange Resins, including the new flexible AMBERCHROM™ HP S60 Polishing Resign designed to handle the high titres from upstream bioprocessing, improving selectivity and throughput, while lowering costs to produce proteins, including antibodies of recombinant or natural origin;
- High-purity Propylene Glycol USP/EP approved for a wide variety of pharmaceutical formulation uses, such as a solvent, extractant, emollient, humectant, coupling agent, dispersant and more;
- OPTIM™ Synthetic Glycerine which complies with all leading standards and pharmacopoeias and is the purest and most stable glycerine on the market today for applications such as a solvent, humectant, antimicrobial preservative, emollient, plasticizer, sweetening agent and a viscosity modifier.
Dow experts from around the world will be at the show to discuss topics of interest to visitors.
In addition to attending AAPS, Dow will also be present at the CPhI Worldwide 2012 in Feria de Madrid, Spain, from October 9th to 11th. In the meantime, visit www.dowhealthcareandmedical.com to learn more about Dow’s commitment to collaborate for a healthier future.
About Dow
Dow combines the power of science and technology to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's diversified industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 160 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture. In 2011, Dow had annual sales of $60 billion and employed approximately 52,000 people worldwide. The Company's more than 5,000 products are manufactured at 197 sites in 36 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.